Betapace and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Betapace (sotalol hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Joint pain when taking Betapace. It is created by eHealthMe based on reports of 2,718 people who have side effects when taking Betapace from the FDA, and is updated regularly.

What is Betapace?

Betapace has active ingredients of sotalol hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 2,899 Betapace users. Check the latest studies of Betapace.

What is Joint pain?

Joint pain is found to be associated with 3,329 drugs and 5,209 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 26, 2026

2,718 people reported to have side effects when taking Betapace.
Among them, 81 people (2.98%) have Joint pain.

Among these 81 people:

How long have people been on Betapace when they have Joint pain? *

What is the gender of people who have Joint pain when taking Betapace? *

female: 40.74 %
male: 59.26 %

What is the age of people who have Joint pain when taking Betapace? *

What are other drugs people take besides Betapace? *

What are other side effects people have besides Joint pain? *

Oedema Peripheral (superficial swelling): 27 people, 33.33%
Pain: 25 people, 30.86%
Cardiac Failure Congestive: 24 people, 29.63%
Back Pain: 23 people, 28.40%
Fainting (loss of consciousness and postural tone): 23 people, 28.40%
Stress And Anxiety: 21 people, 25.93%
Fatigue (feeling of tiredness): 21 people, 25.93%
Dizziness: 21 people, 25.93%
Cardiac Arrest: 20 people, 24.69%
Fall: 20 people, 24.69%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 23.46%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 18 people, 22.22%
Depression: 17 people, 20.99%
Stable Angina (a constant chest pain): 17 people, 20.99%
Pain: 8 people, 9.88%
High Blood Pressure: 5 people, 6.17%
Osteoporosis (bones weak and more likely to break): 5 people, 6.17%
Cardiac Disorder: 4 people, 4.94%
Nausea (feeling of having an urge to vomit): 4 people, 4.94%
Oedema (fluid collection in tissue): 4 people, 4.94%

* Approximation only. Some reports may have incomplete information.

Do you take Betapace and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Betapace:

Betapace (2,899 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Betapace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,329 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,209 conditions)

Related publications that referenced our studies

Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sotalol hydrochloride (the active ingredients of Betapace) and Betapace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.